Wikipedia -WSS

Wikipedia

author：hotspot 2025-08-06 05:20:35 - browse：8684

Adam's take main illustration — Molly Ferguson/STAT

Anavex Life Sciences is in a tough spot. The serial dissembler of clinical trial results might be forced, finally, to tell the truth when it reads out its next study in Rett syndrome.

What sets Anavex apart from all the other biotechs on my radar screen is its habit of shifting the goalposts on clinical trials. Twice last year, first in February and then in December, Anavex announced “positive” outcomes from studies of its drug called blarcamesine — except the results were derived from efficacy endpoints that were not part of the original study designs.

If blarcamesine fails to achieve the pre-determined goals of clinical trials, the thinking apparently goes, then just make a post-hoc change to the study goals.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Illumina slashes 2023 revenue projections yet again

WSS

Montana youths win climate lawsuit against state for promoting fossil fuels

How clinical AI models' predictive power can degrade over time

Hospitals are dialing back on venture capital investing

Wellcome Trust names Røttingen as its new CEO

STAT Readout Newsletter: Today in biotech, life science news

BMS, looking to build heart drug business, turns to AI for diagnosis

hotspot

Wikipedia

hotspot

Psychedelics group wrestles with new pharma identity

A fraught question for the kids of Alzheimer’s: Is it coming for us?

Peter Hotez and the public health issue of online harassment

How clinical AI models' predictive power can degrade over time

Tori Bowie and the unacceptable rates of Black maternal death

European regulators consider appeal over Amylyx ALS drug

In age of alternative facts, a scholarly course on calling out crap

Cancer cells are shown to suck energy source from immune cells

Tori Bowie and the unacceptable rates of Black maternal death

Life sciences deals on track to hit lowest point since 2017

hotspot

Illumina slashes 2023 revenue projections yet again

Health AI: on the border between health care and tech

Life sciences deals on track to hit lowest point since 2017

Treatments for cramps don't cut it. Why aren't there better options?

Schizophrenia gene found to be linked to cells' energy dysfunction

Megan Rapinoe shares emotional post following US Women's World Cup exit

knowledge

focus

knowledge

explore